{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:18:23Z","timestamp":1759335503476},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.cvsm.2004.01.002","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:20Z","timestamp":1113836000000},"page":"725-737","source":"Crossref","is-referenced-by-count":8,"title":["Immunomodulating agents"],"prefix":"10.1016","volume":"34","author":[{"given":"Cecil P","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2004.01.002_BIB1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/1523-1747.ep12462009","article-title":"The effect of cyclosporine A on epidermal cells II. Cyclosporine A inhibits proliferation of normal and transformed keratinocytes","volume":"90","author":"Furue","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1097-4652(200009)184:3<400::AID-JCP15>3.0.CO;2-W","article-title":"Cyclosporine has a direct effect on the differentiation of a mucin-secreting cell line","volume":"184","author":"Phillips","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB3","first-page":"653","article-title":"Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model","volume":"42","author":"Moore","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB5","first-page":"1017","article-title":"Effects of the new anti-lymphocytic peptide cyclosporin A in animals","volume":"32","author":"Borel","year":"1977","journal-title":"Immunology"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0896-8411(92)90031-K","article-title":"The effects of cyclosporin A on non-T cell components of the immune system","volume":"5","author":"Thomson","year":"1992","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB7","first-page":"72","article-title":"A potent immunosuppressant FK506 inhibits IL-8 expression in human eosinophils","volume":"1","author":"Kohyama","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.cvsm.2004.01.002_BIB8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1096-2867(97)80028-X","article-title":"Cyclosporine and tacrolimus","volume":"12","author":"Vaden","year":"1997","journal-title":"Semin Vet Med Surg"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1463-5224.1998.00039.x","article-title":"Cyclosporine A in veterinary ophthalmology","volume":"1","author":"Gilger","year":"1998","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB10","series-title":"Cyclosporin: mode of action and clinical application","first-page":"252","article-title":"Pharmacokinetics of cyclosporin A","author":"Grevel","year":"1989"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB11","first-page":"1362","article-title":"Ocular penetration of cyclosporin A, the rabbit eye","volume":"31","author":"Ben Ezra","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.69.8.600","article-title":"Prolonged survival of allogenic corneal grafts in rabbits treated with topically applied cyclosporin A. Systemic absorption and local immunosuppressive effect","volume":"69","author":"Foets","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00007890-198903000-00023","article-title":"Cyclosporine pharmacokinetics in cats following topical ocular administration","volume":"47","author":"Gregory","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1989.01070020276038","article-title":"Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops","volume":"107","author":"Kaswan","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB15","first-page":"269","article-title":"Topical application of cyclosporine in the management of keratoconjunctivitis sicca in dogs","volume":"26","author":"Salisbury","year":"1990","journal-title":"J Am Anim Hosp Assoc"},{"issue":"1","key":"10.1016\/j.cvsm.2004.01.002_BIB16","first-page":"5","article-title":"Effects of ophthalmic cyclosporine on lacrimal gland pathology and function in dogs with keratoconjunctivitis sicca","volume":"5","author":"Bounous","year":"1995","journal-title":"Vet Comp Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2460\/javma.1991.199.08.1039","article-title":"Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Olivero","year":"1991","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/vr.137.20.504","article-title":"Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial","volume":"137","author":"Sansom","year":"1995","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-2427(95)05471-5","article-title":"Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine","volume":"49","author":"Gilger","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB20","first-page":"269","article-title":"Chronic superficial keratitis in dogs: a placebo controlled trial of topical cyclosporine treatment","volume":"1","author":"Jackson","year":"1991","journal-title":"Prog Vet Comp Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB21","first-page":"635","article-title":"Comparison of topical cyclosporin and dexamethasone for the treatment of chronic superficial keratitis in dogs","volume":"137","author":"Williams","year":"1995","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1748-5827.1995.tb02821.x","article-title":"Treatment of canine nictitans plasmacytic conjunctivitis with 0.2% cyclosporin ointment","volume":"36","author":"Read","year":"1995","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/vr.137.7.170","article-title":"Cyclosporine-responsive keratoconjunctivitis in the cat and horse","volume":"137","author":"Read","year":"1995","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1463-5224.2001.00150.x","article-title":"Feline eosinophilic conjunctivitis","volume":"4","author":"Allgoewer","year":"2001","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB25","unstructured":"Roberge K, Papich M, Krysburg L, Ehelhauser HF, Robinson M, Gilger BC. In vitro studies of trans-scleral delivery of cyclosporine to the equine eye: ocular parameters, drug diffusion, and analysis of a new delivery system [abstract 19]. Presented at the 32nd Annual Meeting of the American College of Veterinary Ophthalmologists, Sarasota, October 10\u201313, 2001. Vet Ophthalmol 2001;4(4):292."},{"key":"10.1016\/j.cvsm.2004.01.002_BIB26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2460\/ajvr.1995.56.07.880","article-title":"Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca","volume":"56","author":"Salisbury","year":"1995","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB27","first-page":"3272","article-title":"Modes of action of FK506, cyclosporin A, and rapamycin","volume":"26","author":"Morris","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease","volume":"135","author":"Rikkers","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB29","first-page":"2737","article-title":"Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye","volume":"34","author":"Pleyer","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB30","doi-asserted-by":"crossref","unstructured":"Berdoulay A, English RV, Nadelstein B, Weigt A. The effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Presented at the 34th Annual Conference of the American College of Veterinary Ophthalmologists, Coeur D'Alene, ID, October 22\u201325, 2003, p. 33.","DOI":"10.1111\/j.1463-5224.2005.00390.x"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB31","unstructured":"Adkins EA, Hendrix DVH, Stuffle JL, Ward DA, Skorobohadv BJ. An investigation of the safety and efficacy of topical ophthalmic application of tacrolimus in dogs [abstract 42]. Presented at the 34th Annual Meeting of the American College of Veterinary Ophthalmologists, Coeur D'Alene, ID, October 22\u201325, 2003. Vet Ophthalmol 2003;6(4):358."},{"key":"10.1016\/j.cvsm.2004.01.002_BIB32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0039-6257(91)90186-J","article-title":"Immunosuppressive drugs in immune and inflammatory ocular disease","volume":"35","author":"Hemady","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0195-5616(90)50058-3","article-title":"Control of ocular inflammation","volume":"20","author":"Wilkie","year":"1990","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB34","first-page":"64","article-title":"Azathioprine in treatment for ocular nodular episcleritis","volume":"80","author":"Schadler","year":"1985","journal-title":"Vet Med"},{"issue":"12","key":"10.1016\/j.cvsm.2004.01.002_BIB35","first-page":"1581","article-title":"Nodular granulomatous episclerokeratitis in dogs;19 cases (1973\u20131985)","volume":"190","author":"Paulsen","year":"1987","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB36","series-title":"Veterinary pharmacology and therapeutics","first-page":"1120","article-title":"Ophthalmic pharmacology","author":"Moore","year":"2001"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB37","series-title":"Small animal clinical pharmacology and therapeutics","first-page":"330","article-title":"Chemotherapy","author":"Barton","year":"2001"},{"issue":"1","key":"10.1016\/j.cvsm.2004.01.002_BIB38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1463-5224.2002.00215.x","article-title":"Treatment of granulomatous meningoencephalomyelitis in a dog","volume":"5","author":"Nuhsbaum","year":"2002","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB39","unstructured":"Knollinger AM, Moore PA, Dietrich U, Dey T, Vidyashankar A. Canine optic neuritis: 25 cases (1992\u20132001) [abstract 37]. Presented at the 33rd Annual Meeting of the American College of Veterinary Ophthalmologists, Denver, October 9\u201313, 2002. Vet Ophthalmol 2002;5(4):293\u20134."},{"key":"10.1016\/j.cvsm.2004.01.002_BIB40","first-page":"1309","article-title":"Hyperviscosity syndrome associated with lymphocytic leukemia in three dogs","volume":"170","author":"MacEwen","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB41","unstructured":"Cuddon PA, Coates JR, Murray M. New treatments for granulomatous meningoencephalomyelitis. Presented at the 20th American College of Veterinary Internal Medicine Forum, Dallas, May 29\u2013June 1, 2002. p. 319\u201321."},{"issue":"9","key":"10.1016\/j.cvsm.2004.01.002_BIB42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1474-4422(03)00505-2","article-title":"New and imaging treatment options for multiple sclerosis","volume":"2","author":"Polman","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB43","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5326\/15473317-33-6-540","article-title":"Tetracycline and niacinamide for the treatment of sterile pyogranuloma\/granuloma syndrome in a dog","volume":"33","author":"Rothstein","year":"1997","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB44","first-page":"1672","article-title":"Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication","volume":"50","author":"Weiss","year":"1989","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB45","first-page":"79","article-title":"Efficacy of low dose oral natural human interferon alpha in acute feline herpesvirus-1 (FHV-1) infection. A preliminary dose determination trial","volume":"27","author":"Nasisse","year":"1996","journal-title":"Proc Am Coll Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB46","doi-asserted-by":"crossref","unstructured":"Riis RC. Interferon treatment of idiopathic ocular granulomatous disease of collies [abstract 001]. Presented at the 31st Annual Meeting of the American College of Veterinary Ophthalmologists, Montreal, October 11\u201315, 2000. Vet Ophthalmol 2000;3(4):247.","DOI":"10.1046\/j.1463-5224.2000.00153.x"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archneur.56.9.1079","article-title":"Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics","volume":"56","author":"Rudick","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cvsm.2004.01.002_BIB48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJMe020157","article-title":"Integrins as the therapeutic targets in autoimmune disease","volume":"348","author":"von Andrian","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561604000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561604000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T23:51:43Z","timestamp":1706140303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561604000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0195561604000038"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2004.01.002","relation":{},"ISSN":["0195-5616"],"issn-type":[{"type":"print","value":"0195-5616"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}